Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

Overview of attention for article published in The Lancet Rheumatology, April 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#47 of 1,272)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 3 news outlets
twitter: 293 X users

guideline: 2 clinical guideline sources

Readers on

mendeley: 259 Mendeley

So far, Altmetric has seen 4 news stories from 3 outlets.

Latest data on COVID-19 patients with rheumatic diseases revealed in registry

Pediatric News , 28 Jul 2025

Prior to the creation of the registries, there were no data available to guide rheumatologists in clinical decision making for…

Latest data on COVID-19 patients with rheumatic diseases revealed in registry

Pediatric News , 23 Apr 2020

An international registry of adult and pediatric rheumatology patients is beginning to identify trends in the types of patients…

First data from the COVID-19 Global Rheumatology Alliance released

medwireNews, 20 Apr 2020

medwireNews: The COVID-19 Global Rheumatology Alliance has released preliminary data on 110individuals with rheumatic disease…

Early Data Suggests People Taking Hydroxychloroquine and Other Autoimmune Drugs Aren't Fully Protected From COVID-19

The Epoch Times, 19 Apr 2020

Dozens of people taking hydroxychloroquine and other autoimmune drugs for chronic ailments such as lupus and rheumatoid…